八旬患者腹主动脉瘤腔内与开放修复的长期结局比较
本研究回顾性分析了2007至2012年接受择期腹主动脉瘤修复的314例80岁及以上患者(开放96例,EVAR 218例),比较两组长期结局。EVAR组早期术后死亡率显著低于开放组(1% vs 14%,P < .001),1年生存率更高(92.9% vs 84.1%,P = .02),但5年生存率无差异,EVAR组再干预率更高(18% vs 2%,P = .05)。
要点
- EVAR显著降低八旬患者择期AAA修复的早期死亡率(1% vs 14%)。
- EVAR组1年生存率更高,但2年及5年生存率与开放组无差异。
- EVAR组再干预率较高(18% vs 2%),高龄患者仍需密切随访。
核心结论
- EVAR较开放修复改善八旬患者1年生存率,但5年生存率相似。
- EVAR组再干预率较高,平均预期寿命超过5年,需 diligent 随访。
研究设计与样本
- 回顾性分析前瞻性收集的血管外科数据库,纳入2007至2012年择期AAA修复的80岁及以上患者314例(开放96例,EVAR 218例),随访至少5年。
- 采用单变量统计比较开放与EVAR两组。
主要发现
- EVAR组早期术后死亡率显著低于开放组(1% vs 14%,P < .001)。
- 总体平均预期寿命5.9年(EVAR 5.8年 vs 开放5.8年,P = .98)。
- 1年生存率EVAR组92.9%显著高于开放组84.1%(P = .02)。
- 2年生存率(EVAR 83.4% vs 开放74.6%,P = .07)和5年生存率(EVAR 57.8% vs 开放60.3%,P = .98)无显著差异。
- 再干预率EVAR组18%高于开放组2%(P = .05)。
临床怎么用
- 对于八旬腹主动脉瘤患者,EVAR可降低围手术期死亡风险,但需告知再干预可能性较高。
- 高龄患者EVAR术后仍需规律影像学随访以监测再干预需求。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- 单中心数据库,样本量有限(314例),结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients older than 80 years have significantly lower early mortality with endovascular aneurysm repair (EVAR) compared with open repair for abdominal aortic aneurysms (AAAs), but long-term results remain poorly studied. We analyzed the results of both emergent and elective AAA repair in patients aged 80 years or older who had at least 5 years of follow-up. METHODS: Retrospective review of a prospectively collected vascular surgery database was performed to identify all patients who underwent elective repair of an AAA between 2007 and 2012 and were 80 years of age or older at the time of surgery. Open and EVAR groups were compared using univariate statistics. RESULTS: The study cohort was composed of 314 patients 80 years of age or older (median, 83 years; interquartile range, 5 years) who underwent repair (96 open, 218 EVAR). The groups had similar comorbidities, except that EVAR patients were more likely to be male and open repair patients were more likely to have larger aneurysms. Compared with open repair, elective early postoperative mortality was significantly lower for EVAR patients (1% vs 14%; P < .001). Overall mean life expectancy was 5.9 years (EVAR, 5.8 years; open repair, 5.8 years; P = .98). The 1-year survival was significantly higher for EVAR (92.9%) than for open repair (84.1%; P = .02). The 2-year survival (EVAR, 83.4%; open repair, 74.6%; P = .07) and 5-year survival (EVAR, 57.8%; open repair, 60.3%; P = .98) did not differ between EVAR and open repair. Reintervention rates (EVAR, 18%; open repair, 2%; P = .05) were higher in the endovascular treatment group. CONCLUSIONS: EVAR results in an improved 1-year mortality in octogenarians compared with open repair, although 5-year survival is similar between the groups. With average life expectancies of >5 years and an 18% reintervention rate, diligent follow-up is required after EVAR even in elderly patients.
引用
- Scallan O, Novick T, Power AH, et al. Long-term outcomes comparing endovascular and open abdominal aortic aneurysm repair in octogenarians. J Vasc Surg. 2019. PMID: 31519509. doi:10.1016/j.jvs.2019.06.207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。